Concepedia

S S Legha

SS

16

Publications

1K

Citations

14

H-Index

1979

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas System

S S Legha is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1979–1999

16

Publications

16

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

S S Legha, Sigrid Ring, Omar Eton et al. · Journal of Clinical Oncology · 1998 · 293 citations

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

Omar Eton, S S Legha, T E Moon et al. · Journal of Clinical Oncology · 1998 · 220 citations

Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults

S S Legha, MJ Keating, KB McCredie et al. · Blood · 1982 · 104 citations · Full text

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.

Isaiah W. Dimery, S S Legha, Mihran Shirinian et al. · Journal of Clinical Oncology · 1990 · 83 citations

, , +12

The role of interferon alfa in the treatment of metastatic melanoma.

S S Legha · PubMed · 1997 · 57 citations

Rows per page

1–5 of 16